Zinzino acquired the rights to the distributor database and related buyer register, stock, and IP rights of the US-based direct gross sales firm Bodē Professional by way of an asset acquisition. That is one other strategic step in Zinzino’s development plans, which deal with bettering private well being and well-being on a worldwide degree with revolutionary biotechnology and a product portfolio marketed by way of direct gross sales.
Bodē Professional is a worldwide direct gross sales firm within the well being phase, working primarily in North America and Japan. Its model portfolio affords a spread of merchandise within the well being and wellness sector. The enterprise has a complete annual turnover of roughly $7 million. The collaboration with Zinzino is predicted so as to add development by way of the synergies that come up within the joint networks, mixed with Zinzino’s test-based product idea and Bodē Professional’s revolutionary product vary.
The partnership can also be anticipated to speed up Zinzino’s growth in Japan. Roughly 55 % of Bodē Professional’s complete income at the moment comes from the Japanese market.
In line with the asset buy settlement, Zinzino can pay a set buy worth of $2 million upon completion, of which 50 % might be settled by way of newly issued Zinzino shares. As well as, there might be a deferred buy worth of $0.4 million and extra buy costs based mostly on future gross sales growth, which at most final result could quantity to $3.6 million. The extra buy worth shall be settled in full with newly issued Zinzino shares. The money portion of the acquisition worth shall be paid from the corporate’s personal money reserves.
“Individualized recommendation and tailor-made options are the longer term, and never simply in well being and wellness,” says Dag Bergheim Pettersen, CEO of Zinzino. Along with BK Boreyko, CEO and founding father of Bodē Professional, “Collectively, now we have a few years of mixed business expertise and all the things it takes to drive the trendy, personalised buying expertise by way of direct gross sales.”
This acquisition follows different strategic acquisitions for Zinzino, together with VMA Life in 2020, Enhanzz in 2022, Xelliss and ACN in 2024 and asset acquisitions of Zurvita, Valentus and Ecosystem in 2025.
